Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways
出版年份 2021 全文链接
标题
Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-12-22
DOI
10.3389/fphar.2021.800522
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long non-coding RNAs: a double-edged sword in aging kidney and renal disease
- (2021) Yan-Ni Wang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Nanoparticle-Mediated Delivery of Emodin via Colonic Irrigation Attenuates Renal Injury in 5/6 Nephrectomized Rats
- (2021) Zhaoyu Lu et al. Frontiers in Pharmacology
- Polyporus Umbellatus Protects Against Renal Fibrosis by Regulating Intrarenal Fatty Acyl Metabolites
- (2021) Yan-Ni Wang et al. Frontiers in Pharmacology
- The Dysregulation of Eicosanoids and Bile Acids Correlates with Impaired Kidney Function and Renal Fibrosis in Chronic Renal Failure
- (2021) Yan-Ni Wang et al. Metabolites
- AGE/RAGE in diabetic kidney disease and ageing kidney
- (2021) Xia-Qing Wu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Rhein protects 5/6 nephrectomized rat against renal injury by reducing inflammation via NF-κB signaling
- (2021) Meiyou Liu et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Emodin-induced autophagic cell death hinders epithelial–mesenchymal transition via regulation of BMP-7/TGF-β1 in renal fibrosis
- (2021) Wei Liu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
- (2021) Shan-Shan Li et al. Frontiers in Pharmacology
- The Effects of Rhubarb for the Treatment of Diabetic Nephropathy in Animals: A Systematic Review and Meta-analysis
- (2021) Jing-Yi Zeng et al. Frontiers in Pharmacology
- Systematic Review and Meta-Analysis of Renin–Angiotensin–Aldosterone System Blocker Effects on the Development of Cardiovascular Disease in Patients With Chronic Kidney Disease
- (2021) Katsunori Yanai et al. Frontiers in Pharmacology
- 1‐Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway
- (2021) Hua Miao et al. BRITISH JOURNAL OF PHARMACOLOGY
- Identification of endogenous 1‐aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation
- (2020) Hua Miao et al. BRITISH JOURNAL OF PHARMACOLOGY
- Renal protection of rhein against 5/6 nephrectomied‐induced chronic kidney disease: role of SIRT3‐FOXO3α signalling pathway
- (2020) Xiaoxiao Wu et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Wnt signaling pathway in aging-related tissue fibrosis and therapies
- (2020) He-He Hu et al. AGEING RESEARCH REVIEWS
- Rhein attenuates renal inflammatory injury of uric acid nephropathy via lincRNA-Cox2/miR-150-5p/STAT1 axis
- (2020) Jiacai Hu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway
- (2020) Fang Dou et al. BIOCHEMICAL PHARMACOLOGY
- Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation
- (2020) Jing-Ru Liu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Emodin Retarded Renal Fibrosis Through Regulating HGF and TGFβ–Smad Signaling Pathway
- (2020) Fan Yang et al. Drug Design Development and Therapy
- Functional Metabolomics Analysis Elucidating the Metabolic Biomarker and Key Pathway Change Associated With the Chronic Glomerulonephritis and Revealing Action Mechanism of Rhein
- (2020) Wei Yu et al. Frontiers in Pharmacology
- A review on the efficacy and mechanism of action of Shenkang injection against chronic kidney disease
- (2020) Jun-Ju Zou et al. BIOMEDICINE & PHARMACOTHERAPY
- Efficacy and safety of Shenkang injection as adjuvant therapy in patients with diabetic nephropathy
- (2020) Yanping Wang et al. MEDICINE
- Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues
- (2020) Hua Miao et al. PHARMACOLOGICAL RESEARCH
- Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation
- (2020) Ming Wang et al. PHYTOMEDICINE
- Astragalus species: Insights on its chemical composition toward pharmacological applications
- (2020) Bahare Salehi et al. PHYTOTHERAPY RESEARCH
- Pharmacokinetics and Pharmacodynamics of the Combination of Rhein and Curcumin in the Treatment of Chronic Kidney Disease in Rats
- (2020) Xiaoying He et al. Frontiers in Pharmacology
- Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
- (2019) Antonio Cuadrado et al. NATURE REVIEWS DRUG DISCOVERY
- Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease
- (2019) Yuan-Yuan Chen et al. Journal of Translational Medicine
- Activated NF-κB/Nrf2 and Wnt/β-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria
- (2019) Ya-Long Feng et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/Axl NF κB/Nrf2 axis
- (2019) Dan-Qian Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nutrition in chronic kidney disease: Nephrology Dialysis Transplantation notable advances in 2018
- (2019) Philippe Chauveau NEPHROLOGY DIALYSIS TRANSPLANTATION
- Microbiome–metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease
- (2019) Ya-Long Feng et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
- (2019) Dan-Qian Chen et al. Nature Communications
- Redox signaling in aging kidney and opportunity for therapeutic intervention through natural products
- (2019) Yuan-Yuan Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Chronic Kidney Disease Diagnosis and Management
- (2019) Teresa K. Chen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma
- (2019) Hui Zhao et al. Journal of Translational Medicine
- Chronic kidney disease: Biomarker diagnosis to therapeutic targets
- (2019) Yan-Ni Wang et al. CLINICA CHIMICA ACTA
- Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation
- (2019) Tianyu Qin et al. JOURNAL OF ETHNOPHARMACOLOGY
- A Significant Association Between Rhein and Diabetic Nephropathy in Animals: A Systematic Review and Meta-Analysis
- (2019) Heng-Chang Hu et al. Frontiers in Pharmacology
- Mechanisms of Renal Fibrosis
- (2018) Benjamin D. Humphreys Annual Review of Physiology
- Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment
- (2018) Lin Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis
- (2018) Ming Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Preventive effect of Shenkang injection against high glucose-induced senescence of renal tubular cells
- (2018) Biqiong Fu et al. Frontiers of Medicine
- Natural products for the prevention and treatment of kidney disease
- (2018) Dan-Qian Chen et al. PHYTOMEDICINE
- Natural Products as a Source for Antifibrosis Therapy
- (2018) Dan-Qian Chen et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease
- (2018) Zhi-Hao Zhang et al. Frontiers in Pharmacology
- Emodin ameliorates renal fibrosis in rats via TGF-β1/Smad signaling pathway and function study of Smurf 2
- (2017) Libin Ma et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Chronic Kidney Disease
- (2017) Angela C Webster et al. LANCET
- Renoprotective effects of emodin against diabetic nephropathy in rat models are mediated via PI3K/Akt/GSK‑3β and Bax/caspase‑3 signaling pathways
- (2017) Danqing Jing et al. Experimental and Therapeutic Medicine
- Emodin protects against oxidative stress and apoptosis in HK-2 renal tubular epithelial cells after hypoxia/reoxygenation
- (2017) Hui Chen et al. Experimental and Therapeutic Medicine
- Are the Therapeutic Effects of Huangqi (Astragalus membranaceus) on Diabetic Nephropathy Correlated with Its Regulation of Macrophage iNOS Activity?
- (2017) Hui Liao et al. Journal of Immunology Research
- Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease
- (2017) Dan-Qian Chen et al. Redox Biology
- The Antioxidant Effects of Radix Astragali (Astragalus membranaceus and Related Species) in Protecting Tissues from Injury and Disease
- (2016) Muhammad Shahzad et al. CURRENT DRUG TARGETS
- Inhibitory effects of Shenkang injection and its main component emodin on the proliferation of high glucose-induced renal mesangial cells through cell cycle regulation and induction of apoptosis
- (2016) Shouzhu Xu et al. Molecular Medicine Reports
- Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression
- (2016) Hua Chen et al. Redox Biology
- ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathwayin vivoandin vitro
- (2015) Xiaoxiao Wu et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Carthami flos: a review of its ethnopharmacology, pharmacology and clinical applications
- (2015) Yanhua Tu et al. Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
- Carthami flos: a review of its ethnopharmacology, pharmacology and clinical applications
- (2015) Yanhua Tu et al. Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
- The Molecular Mechanism of Rhein in Diabetic Nephropathy
- (2014) Cong-Cong Zeng et al. Evidence-based Complementary and Alternative Medicine
- Inflammatory processes in renal fibrosis
- (2014) Xiao-Ming Meng et al. Nature Reviews Nephrology
- A Pharmaco-Metabonomic Study on Chronic Kidney Disease and Therapeutic Effect of Ergone by UPLC-QTOF/HDMS
- (2014) Ying-Yong Zhao et al. PLoS One
- Metabolomics in chronic kidney disease
- (2013) Ying-Yong Zhao CLINICA CHIMICA ACTA
- Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) Fries: A review
- (2013) Ying-Yong Zhao JOURNAL OF ETHNOPHARMACOLOGY
- Protective effects of emodin against cisplatin-induced oxidative stress in cultured human kidney (HEK 293) cells
- (2012) Mostafa I. Waly et al. JOURNAL OF APPLIED TOXICOLOGY
- Abrogation of cisplatin-induced nephrotoxicity by emodin in rats
- (2011) Badreldin H. Ali et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells
- (2010) H Y Choi et al. PROSTATE CANCER AND PROSTATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started